San Francisco, CA · founded 2017
Hims & Hers is a direct-to-consumer telehealth company (NYSE: HIMS), founded in 2017 out of the Atomic venture studio and best known for subscription treatments for hair loss, ED, mental health and skincare, and more recently GLP-1 weight-loss medications. It has scaled fast to roughly $2.3B in revenue and expanded into the UK and Europe, running its own compounding-pharmacy and fulfillment operations. The flip side of that growth is heavy regulatory and legal scrutiny — advertising questions around compounded semaglutide, subscription-cancellation complaints, and patent disputes with Novo Nordisk — so it reads as a fast-moving, high-scrutiny consumer-health company rather than a quiet healthtech shop.
see the full file on Hims & Hers Health| Birthing-parent leave | offered |
|---|---|
| Dental | yes |
| Vision | yes |
| Stock purchase plan | yes |
| 401(k) match | 401(k) with employer matching contribution (percentage not disclosed) |
| Unlimited PTO | yes |
| Wellness / mental-health days | 4 days |
| Fully remote roles | yes |
Every claim above is sourced and dated. See sources on the full page.
Work at Hims & Hers Health and something here is wrong or out of date? Tell us at hello@perks.global and we will check it.